The safety of drug treatments for cervical cancer.

about

Assessment of drug therapy problems among patients with cervical cancer at Kenyatta National Hospital, Kenya.

P2860

Q42672342-1BE8A178-D222-4ED7-AAB5-AA121AA390C2

P2860

The safety of drug treatments for cervical cancer.

Item

http://www.wikidata.org/entity/Q38663857

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

The safety of drug treatments for cervical cancer.

@en

type

Item

label

The safety of drug treatments for cervical cancer.

@en

prefLabel

The safety of drug treatments for cervical cancer.

@en

P1476

The safety of drug treatments for cervical cancer.

@en

P2093

Alfonso Dueñas-González

http://www.w3.org/2001/XMLSchema#string

Aurora González-Fierro

http://www.w3.org/2001/XMLSchema#string

Jaime Coronel

http://www.w3.org/2001/XMLSchema#string

Lucely Cetina

http://www.w3.org/2001/XMLSchema#string

P2860

Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: individual patient data meta-analysis

Different strategies of treatment for uterine cervical carcinoma stage IB2-IIB

Global cancer statistics, 2012

Phase III trial of four cisplatin-containing doublet combinations in stage IVB, recurrent, or persistent cervical carcinoma: a Gynecologic Oncology Group study.

Radiation therapy with or without weekly cisplatin for bulky stage 1B cervical carcinoma: follow-up of a Gynecologic Oncology Group trial.

Routine management of locally advanced cervical cancer with concurrent radiation and cisplatin. Five-year results

Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials.

Multicenter phase II trial of topotecan, cisplatin and bevacizumab for recurrent or persistent cervical cancer.

Improved survival with bevacizumab in advanced cervical cancer

P304

169-180

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14740338.2016.1130127

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-12-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26650333

http://www.w3.org/2001/XMLSchema#string

The safety of drug treatments for cervical cancer.

about

P2860

P2860

The safety of drug treatments for cervical cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698